Healthcare provider profile · identity verified

Yosvani Correa, APRN

Nurse Practitioner · ORLANDO, FL · NPI 1972134559

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	727	233
Rosuvastatin Calcium	Rosuvastatin Calcium	524	174
Amlodipine Besylate	Amlodipine Besylate	390	125
Lisinopril	Lisinopril	320	99
Fluticasone Propionate	Fluticasone Propionate	296	83
Metformin Hcl	Metformin Hcl	267	85
Gabapentin	Gabapentin	264	91
Albuterol Sulfate Hfa	Albuterol Sulfate	259	50
Levothyroxine Sodium	Levothyroxine Sodium	246	78
Glipizide	Glipizide	236	75
Losartan Potassium	Losartan Potassium	198	66
Omeprazole	Omeprazole	198	72
Tamsulosin Hcl	Tamsulosin Hcl	192	69
Montelukast Sodium	Montelukast Sodium	173	61
Duloxetine Hcl	Duloxetine Hcl	170	55
Temazepam	Temazepam	168	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	165	72
Pantoprazole Sodium	Pantoprazole Sodium	165	62
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	163	55
Hydrochlorothiazide	Hydrochlorothiazide	157	55
Famotidine	Famotidine	145	46
Metoprolol Succinate	Metoprolol Succinate	140	47
Citalopram Hbr	Citalopram Hydrobromide	136	47
Trazodone Hcl	Trazodone Hcl	135	44
Irbesartan	Irbesartan	130	42
Meloxicam	Meloxicam	125	48
Vitamin D2	Ergocalciferol (Vitamin D2)	120	49
Ibuprofen	Ibuprofen	115	54
Metoprolol Tartrate	Metoprolol Tartrate	115	44
Diclofenac Sodium	Diclofenac Sodium	109	52
Alprazolam	Alprazolam	107	15
Carvedilol	Carvedilol	103	32
Furosemide	Furosemide	98	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	20
Sildenafil Citrate	Sildenafil Citrate	96	22
Glipizide Er	Glipizide	92	29
Alendronate Sodium	Alendronate Sodium	91	32
Donepezil Hcl	Donepezil Hcl	90	31
Azithromycin	Azithromycin	89	76
Methylprednisolone	Methylprednisolone	86	74
Ozempic	Semaglutide	86	19
Tizanidine Hcl	Tizanidine Hcl	83	41
Eliquis	Apixaban	77	24
Metformin Hcl Er	Metformin Hcl	74	26
Clopidogrel	Clopidogrel Bisulfate	70	25
Olmesartan Medoxomil	Olmesartan Medoxomil	69	18
Lorazepam	Lorazepam	68	suppressed
Clonidine Hcl	Clonidine Hcl	65	14
Finasteride	Finasteride	65	21
Sucralfate	Sucralfate	64	15
Escitalopram Oxalate	Escitalopram Oxalate	63	17
Hydralazine Hcl	Hydralazine Hcl	55	20
Pioglitazone Hcl	Pioglitazone Hcl	53	17
Cefdinir	Cefdinir	51	47
Valacyclovir	Valacyclovir Hcl	51	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	18
Sertraline Hcl	Sertraline Hcl	46	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	41
Methocarbamol	Methocarbamol	45	25
Naproxen	Naproxen	45	25
Januvia	Sitagliptin Phosphate	44	15
Azelastine Hcl	Azelastine Hcl	43	11
Mupirocin	Mupirocin	42	22
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Atenolol	Atenolol	39	11
Glimepiride	Glimepiride	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Pregabalin	Pregabalin	35	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Testosterone Cypionate	Testosterone Cypionate	33	suppressed
Allopurinol	Allopurinol	31	12
Farxiga	Dapagliflozin Propanediol	31	15
Latanoprost	Latanoprost	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Ciclopirox	Ciclopirox	28	11
Doxycycline Hyclate	Doxycycline Hyclate	28	28
Meclizine Hcl	Meclizine Hcl	28	11
Celecoxib	Celecoxib	27	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	11
Baclofen	Baclofen	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Cilostazol	Cilostazol	24	suppressed
Nitroglycerin	Nitroglycerin	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Ondansetron Hcl	Ondansetron Hcl	22	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	21
Bumetanide	Bumetanide	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Simvastatin	Simvastatin	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Methimazole	Methimazole	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	15	suppressed
Cromolyn Sodium	Cromolyn Sodium	15	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	14
Linzess	Linaclotide	15	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Prednisone	Prednisone	13	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Nystatin	Nystatin	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error